AB Science - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 34 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

AB Science - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'AB Science - Product Pipeline Review - 2014', provides an overview of the AB Science's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AB Science's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of AB Science including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of AB Science's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the AB Science's pipeline products

Reasons to buy

- Evaluate AB Science's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of AB Science in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the AB Science's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of AB Science and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of AB Science
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of AB Science and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
AB Science Snapshot 4
AB Science Overview 4
Key Information 4
Key Facts 4
AB Science - Research and Development Overview 5
Key Therapeutic Areas 5
AB Science - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
AB Science - Pipeline Products Glance 10
AB Science - Late Stage Pipeline Products 10
Filing rejected/Withdrawn Products/Combination Treatment Modalities 10
Phase III Products/Combination Treatment Modalities 11
AB Science - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
AB Science - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
AB Science - Drug Profiles 14
masitinib 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecule to Antagonize KIT816 for Aggressive Mastocytosis, Seminoma and AML 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecule to Antagonize VEGFR2 for Kidney Cancer 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule to Inhibit BCR-Abl/LYN for Chronic Myelocytic Leukemia 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
AB Science - Pipeline Analysis 20
AB Science - Pipeline Products by Target 20
AB Science - Pipeline Products by Route of Administration 22
AB Science - Pipeline Products by Molecule Type 23
AB Science - Pipeline Products by Mechanism of Action 24
AB Science - Recent Pipeline Updates 26
AB Science - Dormant Projects 31
AB Science - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34

List of Tables
AB Science, Key Information 4
AB Science, Key Facts 4
AB Science - Pipeline by Indication, 2014 6
AB Science - Pipeline by Stage of Development, 2014 8
AB Science - Monotherapy Products in Pipeline, 2014 9
AB Science - Filing rejected/Withdrawn, 2014 10
AB Science - Phase III, 2014 11
AB Science - Phase II, 2014 12
AB Science - Discovery, 2014 13
AB Science - Pipeline by Target, 2014 21
AB Science - Pipeline by Route of Administration, 2014 22
AB Science - Pipeline by Molecule Type, 2014 23
AB Science - Pipeline Products by Mechanism of Action, 2014 25
AB Science - Recent Pipeline Updates, 2014 26
AB Science - Dormant Developmental Projects,2014 31
AB Science, Other Locations 32